Austin, Texas – November 11, 2024

Clinion has won the SCDM Innovation Award for Clinical Data Science Implementation Excellence at the 2024 SCDM Annual Conference in Boston. This global recognition acknowledges our role in transforming clinical data management through the integration of AI and GenAI technologies.

It highlights our commitment to improving clinical trial efficiency by automating key processes and simplifying data management. Our innovative solutions enable clients to run faster, more cost-effective trials with greater precision and fewer resources.

What makes Clinion stand out?

Clinion stands out as the world’s first AI-driven eClinical platform, uniquely designed to integrate cutting-edge AI and GenAI technologies into every phase of the clinical trial process.                                                                                                        Here’s how Clinion is using AI to drive efficiency:

CDASH Annotation with AI
Clinion’s AI-driven CDASH Annotation simplifies the traditionally manual task of creating annotated Case Report Forms (CRFs). Our AI automatically maps study data to CDASH standards, reducing human error and ensuring compliance. This automation accelerates the preparation of annotations, making CRFs consistent and adhering to industry standards, and cutting study setup time by 30%.

Gen AI-Powered Data Review: Empowering Data Managers
Clinion's revolutionary Gen AI-powered data review tool empowers data managers to instantly generate datasets and raise queries, removing the dependency on biostatisticians. Using simple English prompts, data managers can create any kind of dataset and then review and raise queries directly from the datasets. This self-serve capability accelerates the data review process, improves data quality, and saves valuable hours of manual effort.

Dynamic Reporting with Gen AI: Real-Time Insights
Traditional reporting methods are often slow and complex, delaying the availability of actionable insights. Clinion EDC’s Gen AI technology solves this by enabling data managers to instantly generate custom reports and visualizations. These reports can be saved, scheduled at regular intervals, and shared with stakeholders in real time, enabling faster, more informed decision-making.

At Clinion, we’re replacing outdated methods with innovative AI solutions, transforming data management for greater speed and efficiency in clinical trials.

“We are honored to receive the SCDM Innovation Award, which reflects our commitment to advancing clinical data management through cutting-edge AI and automation,” said Manuj Vangipurapu, Founder & CEO of Clinion. “Our mission has always been to simplify complex trial processes while ensuring exceptional data accuracy and operational efficiency. This recognition validates our efforts and motivates us to continue delivering transformative solutions that redefine the industry.”

Clinion is setting a new standard in clinical trial management, leading the charge in innovation and excellence. This award inspires us to push the boundaries even further, advancing the future of clinical trials with state-of-the-art solutions.

About the SCDM Innovation Awards

The SCDM Innovation Awards honor organizations that have pioneered groundbreaking solutions to advance clinical research and transform healthcare. These awards celebrate innovations driving the evolution of clinical trials and the broader healthcare landscape, contributing to meaningful progress across the industry.

About Clinion

Clinion is an eClinical platform offering a comprehensive range of solutions, including EDC, RTSM, CTMS, eCOA, Document Automation, eTMF, and Safety Solutions, all designed to streamline and accelerate clinical trials. Renowned for our award-winning innovations, Clinion leads the way with AI, ML, and GenAI technologies that shorten trial timelines, enhance compliance, and reduce costs.